Sanofi teams up with Medtronic for diabetes drug delivery technologies
This article was originally published in Clinica
Parisian big pharma Sanofi and US medical device giant Medtronic are planning to team up under an "open innovation" alliance to develop diabetes drug-device combinations focused on improving patient adherence to medicines.
You may also be interested in...
In an exclusive interview, Barbara Lueckel, global head of research technologies at Roche Pharma Partnering, talks about the rationale behind the 2020 deals with Bicycle Therapeutics and Nimble Therapeutics. She gives insight into how deal makers are shifting gears to make deals happen in the challenging environment of the global coronavirus pandemic.
As the COVID-19 pandemic escalates, companies across the world are preparing to roll out commercial test kits for the detection of SARS-CoV-2.
Biopharmaceutical companies doubled-down on rare disease treatments during the last five years, thanks to a potent combination of scientific discovery and appealing business incentives.